Buying the Dip on Palantir Stock? Read This First

Palantir’s revenue surged 70% year over year to $1.41 billion last quarter, with U.S. commercial revenue up 137% and GAAP margins at 41%, but the article argues the stock remains too expensive. The company’s trailing price-to-sales ratio is 68, shares outstanding have grown 28% over five years, and continued dilution could add roughly $88 billion to market cap at unchanged prices over the next five years. The piece recommends waiting for a further dip before buying PLTR.

Analysis

The key second-order issue is not whether the business is “good” but whether the market has already capitalized nearly all of the best-case operating path. At this valuation, PLTR behaves less like a software compounder and more like a duration asset: even modest multiple compression can swamp several years of growth, especially if growth normalizes from hypergrowth to merely strong growth. That makes the stock unusually sensitive to any sign that commercial expansion is broadening more slowly than headline revenue suggests.

A less discussed risk is that compensation dilution effectively shortens the window for equity holders to realize the operating leverage. If share count keeps compounding at anything near the recent pace, revenue growth has to outrun dilution just to preserve per-share value creation. In that setup, “good quarters” may still be bad for stock performance if they don’t come with a clear pathway to slower SBC or materially higher incremental margins.

The competitive nuance is that the winners from PLTR fatigue are not necessarily direct analytics peers; they’re broader enterprise software platforms with more diversified install bases and easier upsell vectors. If buyers start questioning whether one vertical-specific AI platform deserves a mega-cap multiple, capital can rotate toward names like ADBE and CRM that can monetize AI across larger existing customer footprints with less execution risk. Meanwhile, NVDA and INTC are only tangential beneficiaries through AI infrastructure spend, but they are insulated from the specific concern here: software monetization versus equity dilution.

The contrarian view is that the stock may not need a business problem to correct further; it only needs the market to become less willing to pay for perfection. That creates a near-term setup where the best risk/reward is not a naked short, but a structure that benefits from multiple compression while capping upside if another exceptional print forces momentum buyers back in. The likely catalyst window is the next 1-2 earnings cycles, when investors will focus less on growth rate and more on share count trajectory and forward guidance discipline.

Key Decisions for Investors

• Initiate a bearish PLTR structure into strength: buy 3-6 month puts or put spreads funded on up days. Best risk/reward is a defined-risk downside bet because the stock can de-rate faster than fundamentals deteriorate.
• Pair trade: long ADBE / short PLTR over the next 1-2 quarters. Rationale: both can benefit from AI monetization, but ADBE has a broader revenue base and materially less valuation fragility; this is a relative-value trade on multiple discipline.
• If already long PLTR, trim 25-50% into any post-earnings rally and re-enter only after guidance de-risks dilution or the multiple resets materially. Avoid averaging down until the market stops paying for perfection.
• Use CRM as a secondary long versus PLTR in a basket rotation trade. CRM offers similar enterprise AI narrative exposure with lower single-product concentration risk and a more forgiving valuation regime.
• Do not short PLTR outright ahead of earnings unless borrow is cheap and liquidity is ample; the better setup is selling upside calls against long exposure or using put spreads to control squeeze risk.